Diligent Robotics is turning Moxi hospital robots into a clinical logistics layer

Serve Robotics agreed to acquire Diligent Robotics on January 20, 2026, valuing Diligent common stock at $29 million with up to $5.3 million in performance-based consideration. The acquisition put Moxi's hospital operating record in view: more than 1.25 million deliveries, nearly 100 robots, and more than 25 hospital facilities.

Andrea Thomaz and Vivian Chu founded Diligent in 2017 after careers in human-robot interaction. Thomaz is CEO and co-founder, with MIT Media Lab and University of Texas at Austin social robotics work behind the company origin. Chu is co-founder and chief innovation officer. Diligent raised $25 million in new financing in September 2023, with Canaan leading the round.

Moxi is built for non-patient-facing hospital logistics: medications, lab samples, supplies, and equipment. The robot does not need to replace clinical judgment; it needs to reduce routine walking and delivery burden so nurses and other staff stay closer to patient care. Diligent marked its one millionth delivery with Moxi #119 at a Midwest academic health system on a route between an inpatient pharmacy and an outpatient infusion center.

Moxi 2.0 turns that field data into the next product cycle. Diligent unveiled the update in October 2025 after collecting three years of deployment data from busy hospital environments. The new hardware uses NVIDIA IGX Thor and is designed for service panels, handles, denser indoor routing, and obstacles such as beds and wheelchairs.

The competitive field includes Aethon/TUG hospital robots, Relay Robotics, Swisslog hospital logistics, Fetch/Zebra AMRs, pharmacy automation vendors, and human courier workflows inside hospitals. Diligent's distinction is social-robotics-informed hospital deployment with a visible delivery count and a humanoid form designed around staff-facing logistics rather than patient interaction.

Public material still does not disclose hospital-level retention, utilization by robot, route-level uptime, maintenance response time, or detailed annual sales by site beyond Serve's expected $200,000 to $400,000 per hospital range. The strategic question is whether dense Moxi fleets can become normal clinical logistics infrastructure. If hospitals operate 15-plus robots per site with stable utilization, Diligent becomes a hospital workflow layer inside Serve's broader physical AI portfolio.

Have a robotics update Korthos should review? Send news, deployments, product releases, funding rounds, research, or media to tips@korthos.xyz or reach out on X at @agkorthos.